Policy Analysis & Guidance: U.S. Tariffs on Pharmaceuticals and Their Impact on China's Medical Industry
Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma
CompanyDrug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

AbbVie's Rinvoq Approved in EU for Giant Cell Arteritis
CompanyDrug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Bristol Myers Squibb's Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer
CompanyDrug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer

Yifan Pharma Secures NMPA Approval for Generic Sedapain
CompanyDrug

Yifan Pharma Secures NMPA Approval for Generic Sedapain

Yunnan Baiyao's INR102 Gains NMPA Clinical Trial Clearance for Prostate Cancer
CompanyDrug

Yunnan Baiyao’s INR102 Gains NMPA Clinical Trial Clearance for Prostate Cancer

Shanghai Kehua Bioengineering Launches Xi'an Medical Complex Project
CompanyDeals

Shanghai Kehua Bioengineering Launches Xi’an Medical Complex Project

HuidaGene's hfCas12Max Licensed to Vita Therapeutics for Neuromuscular Cell Therapy
CompanyDeals

HuidaGene’s hfCas12Max Licensed to Vita Therapeutics for Neuromuscular Cell Therapy

NMPA Optimizes Drug Manufacturing License Process with Digital QR Codes
Policy / Regulatory

NMPA Optimizes Drug Manufacturing License Process with Digital QR Codes

Bayer Submits Eylea 8 mg for RVO Macular Edema Approval in EU
CompanyDrug

Bayer Submits Eylea 8 mg for RVO Macular Edema Approval in EU

Aidea Pharma Terminates COVID-19 Drug Collaboration with PharmaBlock
CompanyDeals

Aidea Pharma Terminates COVID-19 Drug Collaboration with PharmaBlock

Daiichi Sankyo and AstraZeneca's Datroway Approved in EU for Breast Cancer
CompanyDrug

Daiichi Sankyo and AstraZeneca’s Datroway Approved in EU for Breast Cancer